glp-1 immune system Frontiers Anti-inflammatory properties of GLP-1 receptor

Semaglutide GLP-1 is a medication often used in our clinic to aid in weight loss by regulating appetite and insulin levels, making it an effective option for many of our patients

Administration is usually via subcutaneous injection, though oral semaglutide (Rybelsus) is available for type 2 diabetes only

Wegovy oral (semaglutide pill) , FDA-approved for weight loss in late 2025 and launched January 2026, runs $149$299/mo through manufacturer direct programs and select telehealth routes

Medicare typically covers semaglutide only for type 2 diabetes

Semaglutide causes the stomach to empty more slowly and may impact how the body absorbs any oral medications taken at the same time, Novo Nordisk, maker of semaglutide, said in a statement

Boland BS, Edelman SV, Wolosin JD